Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Sep 3 - Sep 8
Months 3-6: Peak Cumulative Effects What the research suggests: Long-term GHRP cytoprotective effects accumulate chronic GHRP-6 treatment reduces cardiac fibrosis in hypertensive animal models GHRP-6 does not appear to show the same degree of GH-response attenuation as hexarelin with prolonged use Sustained cardioprotective pathway activation (PPARgamma upregulation, anti-fibrotic signaling) requires ongoing dosing (Berlanga-Acosta et al., 2017) What users commonly report: Peak body composition improvements Sustained recovery and performance benefits Continued skin and tissue quality improvements Appetite effect persists but becomes more manageable with routine Some users reduce dosing frequency while maintaining results Realistic expectation: By months 3-6, you have reached steady-state benefits
Cost Considerations and Sourcing Expected Costs Budget planning for Tesamorelin/Ipamorelin therapy: Initial investment: Peptide vials: $150-400 per month (depending on dose and source) Bacteriostatic water: $10-20 Syringes and supplies: $15-30 Initial lab work: $200-500 Monthly ongoing costs: Peptides: $150-400 Supplies: $15-30 Follow-up labs (quarterly): $50-125 monthly average Annual estimate: $2,000-5,500 depending on dosing protocol and lab frequency Quality and Sourcing Considerations Peptide quality varies significantly
In turn, reduced inflammation may lead to a lower risk of various life-threatening diseases
E., El-Kholy, W., Riedel, M., Salapatek, A
